BriaCell Therapeutics reported total assets of $27.07M and total liabilities of $3.66M for the quarter ended Apr 2026, up 59.2% year over year. This balance sheet covers 24 quarters of results from Aug 2019 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Aug2019 | Jul2020 | Jan2021 | Apr2021 | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 57.27M | 47.98M | 44.53M | 41.04M | 37.45M | 33.50M | 28.17M | 21.25M | 13.65M | 6.24M | 0.94M | 0.86M | 5.79M | 5.01M | 12.46M | 10.49M | 2.71M | 29.90M | 6.88M | |||||
| Receivables - NetNet Receivables | 0.01M | 0.03M | 0.01M | 0.02M | 0.03M | 0.01M | 0.01M | 5.70M | 0.02M | 0.03M | 0.02M | 2.79M | 2.43M | 2.15M | 2.32M | 2.06M | 1.17M | 2.28M | 2.59M | |||||
| Receivables - OtherOther Receivables | 0.08M | 0.04M | 0.47M | 0.12M | ||||||||||||||||||||
| Receivables | 0.01M | 0.03M | 0.01M | 0.10M | 0.03M | 0.01M | 0.01M | 5.74M | 0.02M | 0.03M | 0.02M | 3.27M | 2.43M | 2.15M | 2.32M | 2.18M | 1.17M | 2.28M | 2.59M | |||||
| Prepaid Assets | 0.52M | 1.28M | 0.74M | 0.43M | 1.32M | 4.84M | 4.74M | 5.47M | 4.58M | 1.32M | 1.39M | |||||||||||||
| Current Assets | 57.80M | 48.32M | 46.23M | 42.35M | 38.22M | 33.94M | 29.50M | 26.95M | 18.41M | 11.74M | 5.53M | 3.65M | 8.22M | 7.16M | 14.79M | 19.93M | 11.35M | 32.18M | 25.39M | |||||
| Non-Current Assets | ||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.39M | 0.37M | 0.34M | 0.32M | 0.30M | 0.27M | 0.25M | 0.35M | ||||||||||||||||
| Long-Term Investments | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 0.28M | 0.47M | 0.42M | 0.42M | 0.45M | 0.50M | 0.52M | 0.55M | 0.58M | 0.75M | |||||||
| Intangibles | 0.25M | 0.24M | 0.23M | 0.23M | 0.23M | 0.22M | 0.22M | 0.22M | 0.21M | 0.21M | 0.20M | 0.20M | 0.20M | 0.19M | 0.19M | 0.18M | 0.18M | |||||||
| Goodwill & Intangibles | 0.25M | 0.24M | 0.23M | 0.23M | 0.23M | 0.22M | 0.22M | 0.22M | 0.21M | 0.21M | 0.20M | 0.20M | 0.20M | 0.19M | 0.19M | 0.18M | 0.18M | 0.18M | 0.17M | |||||
| Other Non-Current Assets | 1.21M | 1.21M | 1.21M | 1.21M | 0.72M | 0.72M | 0.41M | 0.41M | ||||||||||||||||
| Non-Current Assets | 0.25M | 0.24M | 0.23M | 0.23M | 0.23M | 0.22M | 0.22M | 0.22M | 0.21M | 0.49M | 0.67M | 2.22M | 2.20M | 2.20M | 2.22M | 1.72M | 1.73M | 1.42M | 1.68M | |||||
| Assets | 58.04M | 48.55M | 46.46M | 42.58M | 38.45M | 34.16M | 29.72M | 27.16M | 18.62M | 12.23M | 6.20M | 5.87M | 10.41M | 9.36M | 17.00M | 21.65M | 13.08M | 33.59M | 27.07M | |||||
| Liabilities | ||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||
| Accounts Payables | 0.34M | 0.61M | 0.37M | 0.48M | 0.79M | 0.58M | 1.00M | 1.12M | 0.61M | 3.71M | 6.42M | 7.17M | 4.23M | 5.00M | 3.28M | 3.28M | 2.13M | 1.88M | 2.17M | |||||
| Payables | 0.34M | 0.61M | 0.37M | 0.48M | 0.79M | 0.58M | 1.00M | 1.12M | 0.61M | 3.71M | 6.42M | 7.17M | 4.23M | 5.00M | 3.28M | 3.28M | 2.13M | 1.88M | 2.17M | |||||
| Other Accumulated Expenses | 0.08M | |||||||||||||||||||||||
| Total Current Liabilities | 0.56M | 0.61M | 0.37M | 0.94M | 0.97M | 0.67M | 1.38M | 1.80M | 1.05M | 3.92M | 6.76M | 7.46M | 4.99M | 5.23M | 4.33M | 3.98M | 3.32M | 3.19M | 3.59M | |||||
| Non-Current Liabilities | ||||||||||||||||||||||||
| Minority Interest | -0.21M | -0.24M | -0.27M | -0.30M | -0.33M | -0.38M | -0.47M | -0.55M | -0.63M | -0.70M | -0.65M | |||||||||||||
| Other Non-Current Liabilities | 29.79M | 0.25M | 0.28M | 31.31M | 27.14M | 34.77M | 34.23M | 29.14M | 15.06M | 16.62M | 5.68M | 1.10M | 1.71M | 0.91M | 0.73M | 0.34M | 0.41M | 0.20M | 0.07M | |||||
| Total Non-Current Liabilities | 29.82M | 0.25M | 0.28M | 31.31M | 27.14M | 34.77M | 34.23M | 29.14M | 15.06M | 16.62M | 5.68M | 1.10M | 1.71M | 0.91M | 0.73M | 0.34M | 0.41M | 0.20M | 0.07M | |||||
| Total Liabilities | 30.37M | 32.13M | 36.50M | 32.25M | 28.12M | 35.44M | 35.61M | 30.94M | 16.10M | 20.55M | 12.44M | 8.56M | 6.70M | 6.14M | 5.06M | 4.32M | 3.72M | 3.38M | 3.66M | |||||
| Shareholder's Equity | ||||||||||||||||||||||||
| Common Equity | 27.67M | 1.58M | 16.43M | 9.96M | 10.33M | 10.33M | -1.28M | -5.89M | -3.78M | 2.52M | -8.32M | -6.23M | -2.68M | 3.71M | 3.23M | 11.94M | 17.33M | 9.35M | 30.21M | 23.41M | ||||
| Liabilities and Shareholders Equity | 58.04M | 48.55M | 46.46M | 42.58M | 38.45M | 34.16M | 29.72M | 27.16M | 18.62M | 12.23M | 6.20M | 5.87M | 10.41M | 9.36M | 17.00M | 21.65M | 13.08M | 33.59M | 27.07M | |||||
| Retained Earnings | -29.14M | -22.76M | -27.58M | -60.35M | -61.46M | -73.34M | -78.23M | -80.65M | -74.65M | -85.95M | -84.23M | -85.44M | -91.25M | -97.54M | -103.66M | -111.76M | -119.95M | -127.17M | -134.34M |
Pull BriaCell Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=BCTX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "BCTX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=BCTX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();